Patent · US Active

Crystalline and salt forms of PPAR agonist compounds

US11530192B2 · kind B2 · utility

1Cited by
4References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 19, 2021
Grant dateDec 20, 2022
Priority date
Expiry dateFeb 19, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This disclosure relates to salt forms of compounds capable of activating PPARδ for use in drug substance and drug product development, and related compositions and methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.